Biotechs here struggling to make a buck: with shares under $1, three firms work to avoid Nasdaq delisting.
San Diego Business Journal › October 17, 2005
Linked as:
Extract
Biotechs here struggling to make a buck: with shares under $1, three firms work to avoid Nasdaq delisting.
At the end of the day, some San Diego biotechnology companies long to see George Washington more than you might imagine.
That's because trading under $1 on the Nasdaq stock exchange for more than 30 days earns a company a warning letter that could result in being booted from the exchange. San Diego biotechs La Jolla Pharmaceutical Co., Immune Response Corp. and, most recently, Sequenom, Inc. received such letters from Nasdaq, warning that shares must reach the minimum bid price for 10 consecutive days or risk ...See the full content of this document
Sponsored links
